MDT

88.62

+1.08%↑

VEEV

280.06

-0.3%↓

A

121.12

+1.59%↑

WBA

11.52

0%↓

HQY

103.04

+1.28%↑

MDT

88.62

+1.08%↑

VEEV

280.06

-0.3%↓

A

121.12

+1.59%↑

WBA

11.52

0%↓

HQY

103.04

+1.28%↑

MDT

88.62

+1.08%↑

VEEV

280.06

-0.3%↓

A

121.12

+1.59%↑

WBA

11.52

0%↓

HQY

103.04

+1.28%↑

MDT

88.62

+1.08%↑

VEEV

280.06

-0.3%↓

A

121.12

+1.59%↑

WBA

11.52

0%↓

HQY

103.04

+1.28%↑

MDT

88.62

+1.08%↑

VEEV

280.06

-0.3%↓

A

121.12

+1.59%↑

WBA

11.52

0%↓

HQY

103.04

+1.28%↑

Search

Bio-Rad Laboratories Inc

Fechado

SetorSaúde

251.03 1.81

Visão Geral

Variação de preço das ações

24h

Atual

Mín

246

Máximo

254.78

Indicadores-chave

By Trading Economics

Rendimento

780M

64M

Vendas

-82M

585M

EPS

2.54

Margem de lucro

10.933

Funcionários

7,700

EBITDA

75M

134M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+28.4% upside

Dividendos

By Dow Jones

Próximos Ganhos

31 de jul. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

232M

6.8B

Abertura anterior

249.22

Fecho anterior

251.03

Sentimento de Notícias

By Acuity

50%

50%

162 / 376 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Very Strong Bearish Evidence

Bio-Rad Laboratories Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

8 de jul. de 2025, 19:37 UTC

Grandes Movimentos do Mercado
Aquisições, Fusões, Aquisições de Empresas

M3-Brigade Shares Fall on Merger With ReserveOne

8 de jul. de 2025, 23:45 UTC

Conversa de Mercado

Gold Edges Lower, Weighed by Higher Treasury Yields -- Market Talk

8 de jul. de 2025, 23:42 UTC

Conversa de Mercado

Nikkei May Rise as Yen Weakens -- Market Talk

8 de jul. de 2025, 23:27 UTC

Conversa de Mercado

Australian REITs Yet to Offer Enough Appeal -- Market Talk

8 de jul. de 2025, 23:27 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

8 de jul. de 2025, 23:21 UTC

Conversa de Mercado

Summerset Bull Lauds Strong 2Q Sales Volumes -- Market Talk

8 de jul. de 2025, 23:21 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

8 de jul. de 2025, 22:29 UTC

Aquisições, Fusões, Aquisições de Empresas

Capricorn to Pay A$1.5 Million in Cash and Shares

8 de jul. de 2025, 22:28 UTC

Aquisições, Fusões, Aquisições de Empresas

Capricorn Metals Enters Binding Agreement to Buy Claw Gold Project

8 de jul. de 2025, 21:58 UTC

Conversa de Mercado

Kura Sushi Closely Watching U.S. Tariff Negotiations on Asian Goods -- Market Talk

8 de jul. de 2025, 20:50 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

8 de jul. de 2025, 20:50 UTC

Conversa de Mercado

Tech, Media & Telecom Roundup: Market Talk

8 de jul. de 2025, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

8 de jul. de 2025, 20:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

8 de jul. de 2025, 19:53 UTC

Conversa de Mercado

Copper Posts Biggest One-Day Gain Ever to Hit Record on Tariff Chatter -- Market Talk

8 de jul. de 2025, 19:53 UTC

Conversa de Mercado

Market Talk Roundup: Latest on U.S. Politics

8 de jul. de 2025, 19:45 UTC

Conversa de Mercado

Canada Unlikely to Succeed in Bid for Tariff-Free Trade With U.S. -- Market Talk

8 de jul. de 2025, 19:29 UTC

Conversa de Mercado

U.S. Consumer-Credit Growth Slowed in May -- Market Talk

8 de jul. de 2025, 19:20 UTC

Conversa de Mercado

U.S. Natural Gas Futures Settle Lower -- Market Talk

8 de jul. de 2025, 19:11 UTC

Conversa de Mercado

Bank of Canada's Rate Cuts Deliver Muted Relief Along the Curve -- Market Talk

8 de jul. de 2025, 19:01 UTC

Conversa de Mercado

Oil Futures Gain With Support From Products -- Market Talk

8 de jul. de 2025, 18:49 UTC

Ganhos

Hershey Names New CEO, Continuing Leadership Shuffle. The Stock Falls. -- Barrons.com

8 de jul. de 2025, 18:41 UTC

Conversa de Mercado

Mexico's Inflation Seen Mixed in June -- Market Talk

8 de jul. de 2025, 18:38 UTC

Conversa de Mercado

Gold Falls as Markets Digest Details of Trump Tariffs -- Market Talk

8 de jul. de 2025, 18:23 UTC

Conversa de Mercado

Analysts Anticipate Lower Ethanol Inventories -- Market Talk

8 de jul. de 2025, 18:10 UTC

Conversa de Mercado

Market Talk Roundup: Latest on U.S. Politics

8 de jul. de 2025, 18:10 UTC

Conversa de Mercado

Freeport-McMoRan Jumps on Trump Tariff Plan for Copper Imports -- Market Talk

8 de jul. de 2025, 17:24 UTC

Conversa de Mercado

Election, Dollar Seen as Potential Headwinds for Ibovespa -- Market Talk

8 de jul. de 2025, 17:06 UTC

Conversa de Mercado

KeyCorp and Regional Banks Set for a Catchup -- Market Talk

8 de jul. de 2025, 16:20 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

Comparação entre Pares

Variação de preço

Bio-Rad Laboratories Inc Previsão

Preço-alvo

By TipRanks

28.4% parte superior

Previsão para 12 meses

Média 323 USD  28.4%

Máximo 387 USD

Mínimo 245 USD

Com base em 4 analistas de Wall Street que oferecem metas de preço de 12 meses para Bio-Rad Laboratories Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

4 ratings

3

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

229.835 / 235.8095Suporte e Resistência

Curto Prazo

Very Strong Bearish Evidence

Médio Prazo

Bullish Evidence

Longo Prazo

Bearish Evidence

Sentimento

By Acuity

162 / 376 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Bio-Rad Laboratories Inc

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.